Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia

We evaluated the effect of Acetyl-cholinesterase-inhibitors (AChEIs) on cognitive decline and overall survival in a large sample of older patients with late onset Alzheimer’s disease (LOAD), vascular dementia (VD) or Lewy body disease (LBD) from a real world setting. Patients with dementia enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuin, Marco, Cherubini, Antonio, Volpato, Stefano, Ferrucci, Luigi, Zuliani, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288483/
https://www.ncbi.nlm.nih.gov/pubmed/35842477
http://dx.doi.org/10.1038/s41598-022-16476-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288483/
https://www.ncbi.nlm.nih.gov/pubmed/35842477
http://dx.doi.org/10.1038/s41598-022-16476-w

Ejemplares similares